TD Cowen is Bullish on BrightSpring Health Services, Inc. (BTSG)
On January 27, 2026, TD Cowen upgraded BrightSpring Health Services, Inc. (NASDAQ:BTSG)’s price objective to $46 from $42 while keeping a Buy rating.
Brightspring Health Services Inc. (BTSG)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | 8 Knots Management Scott J. Green | 2,087,076 | $78,160,996 | +21% | 9% |
| 2. | Marshall Wace LLP Paul Marshall And Ian Wace | 1,687,215 | $63,186,202 | +34% | 0.06% |
| 3. | Alta Fox Capital Management Connor Haley | 1,237,500 | $46,344,375 | +169% | 9.97% |
| 4. | Woodline Partners Michael Rockefeller And Karl Kroeker | 1,220,564 | $45,710,122 | +44% | 0.18% |
| 5. | Braidwell LP Alex Karnal | 1,195,786 | $44,782,186 | 1.43% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $11.13 | 11,619,998 | $129,330,577.74 | 92,959,984 | 2024-09-11 | Filing | |
| $11.13 | 11,619,998 | $129,330,577.74 | 92,959,984 | 2024-09-11 | Filing | |
| $11.46 | 1,000 | $11,461.00 | 1,000 | 2024-05-20 | Filing | |
| $8.21 | 3,000 | $24,630.00 | 60,880 | 2024-03-15 | Filing | |
| $8.26 | 6,080 | $50,220.80 | 134,780 | 2024-03-15 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $28.78 | 14,745,000 | $424,390,590.00 | 62,351,337 | 2025-10-22 | Filing | |
| $28.78 | 14,745,000 | $424,390,590.00 | 62,351,337 | 2025-10-22 | Filing | |
| $28.78 | 235,000 | $6,763,770.00 | 1,131,930 | 2025-10-22 | Filing | |
| $28.78 | 20,000 | $575,640.00 | 131,150 | 2025-10-22 | Filing | |
| $21.15 | 2,100,000 | $44,418,990.00 | 77,096,337 | 2025-06-24 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 61,942,032 | $2,319,729,098 | 37.09% | |
| 2. | 22,679,459 | $849,345,750 | 0.04% | |
| 3. | 16,986,262 | $636,135,513 | 0.01% | |
| 4. | 12,533,656 | $469,385,416 | 0.01% | |
| 5. | 10,595,232 | $396,791,439 | 0.06% |
News See All
11 Most Volatile Stocks to Buy According to Hedge Funds
On February 17, 2026, Bloomberg reported that stocks fluctuated significantly as investors assessed the risks of artificial intelligence. The S&P 500 climbed 0.1%, while a software ETF sank 2.2%.
Diverse Growth Signals Lifted BrightSpring Health Services (BTSG) Higher
Carillon Tower Advisers, an investment management company, released its fourth-quarter 2025 investor letter for the “Carillon Eagle Small Cap Growth Fund”.
TIG Analyst Raises BrightSpring (BTSG) PT to $55, Cites Consistent Operational Performance
BrightSpring Health Services Inc. (NASDAQ:BTSG) is one of the best IPO stocks to buy right now.
14 Best IPO Stocks to Buy Right Now
On January 21, Lynn Martin, NYSE president, joined CNBC to discuss the IPO landscape for 2026. Martin predicted a super cycle for IPO activity this year.
Mizuho Raises BrightSpring (BTSG) PT to $45 Despite Signs of Peak Healthcare Demand
BrightSpring Health Services Inc. (NASDAQ:BTSG) is one of the best young stocks to buy and hold for 3 years.
11 Best Young Stocks to Buy and Hold For 3 Years
On December 19, Ben Narasin, Tenacity Venture Capital founder, joined 'Squawk Box' on CNBC to discuss the state of the IPO market and the 2026 IPO pipeline outlook.
BMO Capital Maintains Bullish 12%+ BrightSpring EBITDA Growth Outlook on Drug Contract Wins, Generic Conversions
BrightSpring Health Services Inc. (NASDAQ:BTSG) is one of the best new stocks to invest in.
10 Best New Stocks to Invest In
Earlier on October 28, Liz Myers, JPMorgan's global chairman of investment banking and capital markets, joined 'The Exchange' on CNBC to discuss the state of initial public offerings.
UBS Ups BrightSpring Target to $42, Reiterated Buy After Beat-and-Raise Q3
On October 29, one day after the company's release of Q3 results, UBS analyst A.J. Rice.
Hedge Fund Resource Center